Network origin in Xavier Buyse first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
University of Barcelona
71
| College/University | Other Consumer Services | 71 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Xavier Buyse via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
Palau Pharma SA
 Palau Pharma SA BiotechnologyHealth Technology Palau Pharma SA is a holding company engaged in the discovery and development of biophamaceuticals for the treatment of inflammatory and autoimmune diseases, such as rheumatoid arthritis, neuropathic pain, and chronic obstructive pulmonary disease. The company was founded on March 13, 1991 and is headquartered in Palau Solita i Plegamans, Spain. | Biotechnology | Corporate Officer/Principal Director of Finance/CFO Chief Tech/Sci/R&D Officer General Counsel Chief Tech/Sci/R&D Officer | |
| CAIXABANK, S.A. | Regional Banks | Corporate Officer/Principal Director/Board Member General Counsel Director/Board Member Corporate Officer/Principal | |
Caixa Capital Risc SGEIC SA
 Caixa Capital Risc SGEIC SA Investment ManagersFinance Caixa Capital Risc SGEIC SA (Caixa Capital Risc) is a venture capital armof Criteria Caixa SA founded in 2002. The firm is headquartered in Barcelona, Spain with additional offices in Madrid. | Investment Managers | Private Equity Investor Private Equity Investor Private Equity Analyst Private Equity Investor | |
| Ramon Llull University | College/University | Undergraduate Degree Director/Board Member Graduate Degree Masters Business Admin | |
| University of Navarra | College/University | Masters Business Admin Graduate Degree Masters Business Admin Graduate Degree | |
Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona
 Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona Savings BanksFinance Fundación Bancaria Caixa d'Estalvis i Pensions de Barcelona operates as a banking foundation. It offers retail banking services such as savings accounts, deposits, pension, and insurance, as well as private banking and financial advisory, including personalized investment strategies and portfolio management. The company was founded in 1904 and is headquartered in Barcelona, Spain. | Savings Banks | Director/Board Member Corporate Officer/Principal Chief Executive Officer Comptroller/Controller/Auditor | |
| Escuela Superior de Administración y Dirección de Empresas | College/University | Graduate Degree Graduate Degree Graduate Degree | |
| La Caixa Foundation | Director/Board Member Director/Board Member Director/Board Member | ||
| ORYZON GENOMICS S.A. | Biotechnology | Founder Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Instituto de Estudios Superiores de la Empresa | College/University | Masters Business Admin Masters Business Admin Masters Business Admin | |
SpliceBio SL
 SpliceBio SL BiotechnologyHealth Technology SpliceBio SL is a genetic medicines company based in Barcelona, Spain. The Spanish company harnesses its proprietary protein splicing platform to develop the next generation of gene therapies. SpliceBio's platform offers the potential to address diseases that currently cannot be treated with gene therapies because the necessary gene is too large to be delivered by -associated virus (AAV) vectors. The company's lead program targets Stargardt disease, a genetic eye disease that causes vision loss in children and adults. SpliceBio's platform is based on technology developed in the Muir lab at Princeton University after more than 20 years of pioneering intein and protein engineering research. The company was founded by Dominguez Silvia Frutos, Miquel Vila-Perelló, and Miquel Vila-Perelló has been the CEO since incorporation. | Biotechnology | Director/Board Member Director/Board Member | |
| University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
| AB-BIOTICS, S.A. | Pharmaceuticals: Other | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ASPY GLOBAL SERVICES, S.A. | Financial Conglomerates | Director/Board Member Director/Board Member | |
Minoryx Therapeutics SL
 Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
| PARLEM TELECOM COMPANYIA DE TELECOMUNICACIONS, S.A. | Wireless Telecommunications | Director/Board Member Director/Board Member | |
ADman Interactive SL
 ADman Interactive SL Information Technology ServicesTechnology Services ADman Interactive SL provides video streaming platform. It offers video distribution for instream, out stream and native video. Its products include Intext, In-Banner, I-Spot, and native video. The company was founded by Josep Maria Tribó Capdevila, Marcos David Luengo Sánchez and Victor Sala Gracia in 2010 and is headquartered in Barcelona, Spain. | Information Technology Services | Chief Executive Officer Founder | |
Lanai Partners SL
 Lanai Partners SL Investment ManagersFinance Lanai Partners SL (Lanai Partners) is a venture capital firm founded in 2016 by Jeroen Merchiers, Rubén Ferreiro, Guillermo Llibre and Mar Alarcón The firm is headquartered in Barcelona, Spain. | Investment Managers | Private Equity Investor Private Equity Investor | |
Zera Intein Protein Solutions SL
 Zera Intein Protein Solutions SL BiotechnologyHealth Technology Zera Intein Protein Solutions SL develops and commercializes biomedical technologies, with applications in the biotechnological, pharmaceutical, veterinary and industrial sectors. Its proprietary technologies include Zera and Splittera. Zera technology is composed of self-assembler peptides for DNA vaccines, carrier-free enzyme immobilization, and biopharmaceutical protein production. Splittera refers to Split Intein technology which includes trans-splicing, cyclization, and cleavage reactions. The company was founded on January 30, 2015 and is headquartered in Barcelona, Spain. | Biotechnology | Chief Executive Officer Director/Board Member | |
| ESADE Business School | College/University | Graduate Degree Undergraduate Degree | |
Noucor Health SA
 Noucor Health SA Miscellaneous Commercial ServicesCommercial Services J. Uriach y Cia SA manufactures and markets pharmaceutical products. It offers consumer health products, including over-the-counter drugs, food supplements, personal health and wellbeing products, and nutricosmetic products. The company was founded by Juan Uriach Feliu in 1838 and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Polytechnic University of Catalonia | College/University | Graduate Degree Doctorate Degree | |
Fira Internacional de Barcelona
 Fira Internacional de Barcelona Miscellaneous Commercial ServicesCommercial Services Fira Internacional de Barcelona organizes trade shows and fairs, as well as corporate and socio-cultural events. It offers catering, logistics, transportation, accommodations, registration services for participants and guests. The company was founded in 1932, and is headquartered in Barcelona, Spain. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
AptaTargets SL
 AptaTargets SL Pharmaceuticals: MajorHealth Technology AptaTargets SL is a biopharmaceutical company based in Madrid, Spain that focuses on developing therapeutic applications based on aptamer technology. The Spanish company is currently developing aptoll, an immune modulator that blocks the activation of tlr4 in a stroke, representing a novel approach to treat ischemic stroke in the acute phase. It could also be administered in patients up to 48 hours after the stroke. AptaTargets targets indications where inflammation causes significant damage through clinical studies and successful preclinical development. The company was founded in 2014 by David Segarra and María Eugenia Zarabozo, with David Segarra serving as the CEO since then. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Inveready Asset Management SGEIC SA
 Inveready Asset Management SGEIC SA Investment ManagersFinance Inveready Asset Management SGEIC SA (Inveready) is a private equity and venture capital subsidiary of Inveready Capital Co. SL founded in 2008 by Joseph Maria Echarri Torres. The firm is headquartered in San Sebastian, Spain. | Investment Managers | Chief Executive Officer Private Equity Investor | |
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor Private Equity Investor | |
Ability Pharmaceuticals SL
 Ability Pharmaceuticals SL BiotechnologyHealth Technology Ability Pharmaceuticals SL operates as a clinical stage drug discovery and development biopharmaceutical firm. It develops human therapeutics to treat cancer and other indications with unmet medical needs. The company was founded by Carles Domènech Garcia Jordi Espadaler Mazo in November 2009 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member Director/Board Member | |
| HOLALUZ-CLIDOM, S.A. | Electric Utilities | Chief Executive Officer Corporate Officer/Principal | |
| London Business School | College/University | Masters Business Admin | |
AmacaThera, Inc.
 AmacaThera, Inc. Medical SpecialtiesHealth Technology AmacaThera, Inc. is biotechnology company, which engages in the development and commercialization of injectable hydrogel platform technology. Its platform addresses the critical problem of sustaining therapeutic delivery of pharmacological agents for multiple disease areas. The company was founded by Molly S. Soichet and Mike Cooke and is headquartered in Toronto, Canada. | Medical Specialties | Director/Board Member | |
Agrasys SL
 Agrasys SL BiotechnologyHealth Technology Agrasys SL develops and commercialize crops and cereals. It offers Tritordeum, a non genetic modification cereals and developed for human nutrition. The company was founded in 2005 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
| Indiana University | College/University | Graduate Degree | |
| CHEVRON CORPORATION | Integrated Oil | Private Equity Investor | |
| IFFE FUTURA, S.A. | Real Estate Investment Trusts | Director/Board Member | |
Oxolife SL
 Oxolife SL BiotechnologyHealth Technology Oxolife SL operates as an biotech company focused on treating female infertility. The company was founded by Agn?s Arbat and Ignasi Canals in 2013 and is headquartered in Barcelona, Spain. | Biotechnology | Director/Board Member | |
Innoup Farma SL
 Innoup Farma SL BiotechnologyHealth Technology InnoUp Farma SL develops nanotechnology-based solutions for the administration of oral drugs. It offers anti-cancer drugs with low oral bioavailability. The company was founded by Maite Agueros Bazo, Manuel Rodriguez Mariscal and Juan Manuel Irache Garreta and is headquartered in Noain, Spain. | Biotechnology | Director/Board Member | |
Biotechnology Development for Industry in Pharmaceuticals SLU
 Biotechnology Development for Industry in Pharmaceuticals SLU Miscellaneous Commercial ServicesCommercial Services Biotechnology Development for Industry in Pharmaceuticals SL provides biotechnology solutions to the health and food sectors. Its products include vaccine in animal health, and human health products. It also offers product development, process development, and contract manufacturing services. The company is headquartered in Boecillo, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
| EDESA BIOTECH, INC. | Pharmaceuticals: Major | Director/Board Member | |
Caixabank Asset Management SGIIC SA
 Caixabank Asset Management SGIIC SA Investment ManagersFinance Caixabank Asset Management SGIIC SA (CAM) is the wholly-owned asset management subsidiary of Caixabank SA (MP: CABK, ADR: CAIXY) in Spain. The firm was established in 1983 and is headquartered in Barcelona. CAM develops investment solutions adapted to the profile of each client. They manage a wide range of funds, SICAVs and discretionary management portfolios. In 2016, they reaffirm their commitment to the UN Global Compact by signing the United Nations Principles for Responsible Investment (UNPRI). | Investment Managers | Portfolio Manager-Equities | |
| Escola Tècnica Superior d'Enginyeria Industrial de Barcelona | College/University | Undergraduate Degree | |
| JUNGLE 21, S.A. | Advertising/Marketing Services | Director/Board Member | |
| Institut d'Estudis Financers | College/University | Graduate Degree | |
Altamar Private Equity SGIIC SA /Private Equity/
 Altamar Private Equity SGIIC SA /Private Equity/ Investment ManagersFinance Altamar Private Equity SGIIC SA (Altamar Private Equity) is a private equity arm of Altamar Capital Partners SL founded in 2004. The firm is headquartered in Spain with additional offices in New York and Santiago de Chile. | Investment Managers | Private Equity Investor | |
Nectria SL
 Nectria SL Packaged SoftwareTechnology Services Nectria SL develops software solutions for optimizing fleet management. It combines a strong multidisciplinary skillset with extensive expertise in logistics, AI, software engineering and business management. The company was founded by Mikael Baron, Oriol Serra, David Vega Costa, Miguel Valls Figueras, Victor Tejedo Palmero, Guillem Ricarte and Javier Juncadella in 2012 and is headquartered in Barcelona, Spain. | Packaged Software | Founder | |
Federacion Espanola de Bebidas Espirituosas
 Federacion Espanola de Bebidas Espirituosas Miscellaneous Commercial ServicesCommercial Services Federacion Espanola de Bebidas Espirituosas operates as an association of companies producing and distributing spirits. The private company is based in Madrid, Spain. | Miscellaneous Commercial Services | Director/Board Member | |
| Amer Global Brands SL | Food Distributors | Director/Board Member | |
Grupo Vinicola Marques De Vargas Sl
 Grupo Vinicola Marques De Vargas Sl Beverages: AlcoholicConsumer Non-Durables Grupo Vinicola Marques De Vargas Sl is a family project that operates in three prestigious denominations of origin: Rioja, Ribera del Duero, and Rías Baixas. The private company is based in Logrono, Spain. The Spanish company, known as Bodegas y Viñedos del Marqués de Vargas, values the privacy of its customers and ensures that their personal data is treated in a fair, lawful, and transparent manner. | Beverages: Alcoholic | Director/Board Member | |
| Norte Mg SL | Director/Board Member | ||
| Ron Barceló SRL | Director/Board Member |
Statistics
International
| Spain | 44 |
| United States | 4 |
| Canada | 3 |
| United Kingdom | 2 |
| Dominican Republic | 2 |
Sectoral
| Health Technology | 15 |
| Consumer Services | 12 |
| Finance | 11 |
| Commercial Services | 6 |
| Technology Services | 3 |
Operational
| Director/Board Member | 186 |
| Corporate Officer/Principal | 78 |
| Undergraduate Degree | 51 |
| Graduate Degree | 46 |
| Private Equity Investor | 40 |
Most connected contacts
- Stock Market
- Insiders
- Xavier Buyse
- Company connections
